Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,447 | -27,790 | -18,209 | -8,767 | -38,575 |
| Depreciation Amortization | 1,149 | 824 | 502 | 251 | 723 |
| Accounts receivable | -388 | -771 | -347 | 156 | -259 |
| Accounts payable and accrued liabilities | 384 | -65 | -33 | -306 | -600 |
| Other Working Capital | 669 | -537 | -729 | -1,459 | -89 |
| Other Operating Activity | 7,448 | 6,380 | 3,907 | 1,584 | 9,432 |
| Operating Cash Flow | $-29,185 | $-21,959 | $-14,909 | $-8,541 | $-29,368 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,343 | -1,061 | -452 | -12 | -2,100 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -35 |
| Other Investing Activity | -48 | -48 | 0 | 0 | -35 |
| Investing Cash Flow | $-1,391 | $-1,109 | $-452 | $-12 | $-2,135 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -5 |
| Common Stock Issued | 31,247 | 30,983 | 5,000 | N/A | 43,457 |
| Financing Cash Flow | $31,247 | $30,983 | $5,000 | $N/A | $43,452 |
| Exchange Rate Effect | -11 | -10 | -7 | N/A | N/A |
| Beginning Cash Position | 62,091 | 62,091 | 62,091 | 62,091 | 50,142 |
| End Cash Position | 62,751 | 69,996 | 51,723 | 53,538 | 62,091 |
| Net Cash Flow | $660 | $7,905 | $-10,368 | $-8,553 | $11,949 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,185 | -21,959 | -14,909 | -8,541 | -29,368 |
| Capital Expenditure | -1,354 | -1,061 | -452 | -12 | -2,114 |
| Free Cash Flow | -30,539 | -23,020 | -15,361 | -8,553 | -31,482 |